Giá của Ocean Biomedical, Inc. là bao nhiêu (OCEAW)

Giá của Ocean Biomedical, Inc. (OCEAW) là $0.0298

Mũ thị trường của Ocean Biomedical, Inc. là gì (OCEAW)

Giới hạn thị trường của Ocean Biomedical, Inc. (OCEAW) là $7.94M

Doanh thu Ocean Biomedical, Inc. (OCEAW)

Ocean Biomedical, Inc. is a biopharmaceutical enterprise primarily engaged in identifying and advancing novel therapeutic agents. Their research and development efforts span several key disease areas, including cancer, fibrotic conditions, infectious illnesses, and inflammatory disorders. The company's current development pipeline features both mono-specific and bi-specific humanized monoclonal antibodies (mAbs). These candidates are engineered to target Chi3l1 and are being investigated for treating non-small cell lung cancer and glioblastoma multiforme, a type of brain tumor. Furthermore, Ocean Biomedical is progressing a small molecule therapeutic designed to interact with Chit1, intended for individuals afflicted with Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. Their proprietary WPDS platform has generated three additional product candidates: a vaccine aimed at preventing malaria; a humanized monoclonal antibody treatment; and a small molecule treatment, with both malaria therapeutics specifically targeting the Plasmodium falciparum glutamic-acid-rich protein (PfGARP). The company is also developing a therapy for hospitalized patients suffering from COVID-19. Founded in 2019, Ocean Biomedical's operations are headquartered in Providence, Rhode Island.

Năm	Doanh thu	Thay đổi
Không đủ dữ liệu cho ngày được cung cấp.

Năm

Doanh thu

Thay đổi

Không đủ dữ liệu cho ngày được cung cấp.

Công ty	Doanh thu	Chênh lệch doanh thu	Quốc gia
Vertex Pharmaceuticals Incorporated VRTX.US	$12.62B	-	US
Argenx SE ARGX.US	$6.02B	-	NL
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR
UCB S.A. UCB.BR	$10.11B	-	BE

Công ty

Doanh thu

Chênh lệch doanh thu

Quốc gia